Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing

The stockholders of Black Diamond, Inc. (the "Company") elected the six nominees
for director identified in the Company's proxy statement filed with the
Securities and Exchange Commission on April 30, 2014 (the "Proxy Statement") at
the Company's 2014 Annual Meeting of Stockholders (the "Meeting") held on June
5, 2014. Of the six directors elected, three directors meet the independence
requirements of the NASDAQ Stock Market's ("NASDAQ") Listing Rules (the "Listing
Rules"). As a result, a majority of the Company's Board of Directors (the
"Board") is currently not comprised of directors who meet the independence
requirements of the NASDAQ Listing Rules.

On June 6, 2014, the Company received a letter from NASDAQ stating that the
Company is no longer in compliance with NASDAQ's independent director
requirement as set forth in Listing Rule 5605(b)(1), which requires that a
NASDAQ-listed company's board of directors consist of a majority of "independent
directors" (as defined in Rule 5605(a)(2) of the Listing Rules).

In accordance with Listing Rule 5605(b)(1)(A), and as stated in the letter the
Company received from NASDAQ, the Company has a cure period to regain compliance
with Listing Rule 5605(b)(1) until the earlier of the Company's next annual
shareholders' meeting or June 5, 2015, or if the next annual shareholders'
meeting is held before December 2, 2014, then the Company must evidence
compliance no later than December 2, 2014 (the "Cure Period"). Prior to the end
of the Cure Period, the Board intends to fill the Board vacancy with a qualified
candidate who is considered to be an "independent director" in accordance with
the criteria set forth in Listing Rule 5605(a)(2). Upon such appointment, the
Company will again meet the requirements of Rule 5605(b)(1) of the Listing
Rules.

Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) and (b) Of the 32,497,997 shares of common stock entitled to vote at the
Meeting, 25,380,124 shares of common stock were present in person or by proxy
and entitled to vote, representing approximately 78.1% of the Company's
outstanding shares of common stock.

At the Meeting, the Company's stockholders: (i) approved the re-election of each
of the following six director nominees standing for re-election: Warren B.
Kanders, Robert R. Schiller, Peter Metcalf, Donald L. House, Nicholas Sokolow
and Michael Henning; (ii) approved, on an advisory, non-binding basis, the
Company's executive compensation, as disclosed in the Proxy Statement and (iii)
ratified the appointment of KPMG LLP as the Company's independent registered
public accounting firm for the year ending December 31, 2014. Each proposal is
described in more detail in the Proxy Statement.

The voting results for each proposal are set forth below:

Proposal 1 - To elect six members to serve on the Company's Board until the next
annual meeting of stockholders and until their successors are duly elected and
qualified: